1. Home
  2. RYN vs IBRX Comparison

RYN vs IBRX Comparison

Compare RYN & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rayonier Inc. REIT

RYN

Rayonier Inc. REIT

HOLD

Current Price

$21.57

Market Cap

6.4B

Sector

Real Estate

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.23

Market Cap

7.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYN
IBRX
Founded
1926
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
7.5B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
RYN
IBRX
Price
$21.57
$7.23
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$26.00
$12.57
AVG Volume (30 Days)
2.1M
9.3M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
11.73%
N/A
EPS Growth
26.78
38.71
EPS
N/A
N/A
Revenue
$484,485,000.00
$113,288,000.00
Revenue This Year
$214.97
$88.59
Revenue Next Year
$10.35
$131.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
668.31
52 Week Low
$19.49
$1.95
52 Week High
$27.34
$12.43

Technical Indicators

Market Signals
Indicator
RYN
IBRX
Relative Strength Index (RSI) 50.52 44.23
Support Level $20.98 $6.69
Resistance Level $21.85 $8.46
Average True Range (ATR) 0.56 0.42
MACD -0.01 -0.06
Stochastic Oscillator 38.93 38.59

Price Performance

Historical Comparison
RYN
IBRX

About RYN Rayonier Inc. REIT

Rayonier Inc is a timberland real estate investment trust engaged in the ownership, management, and investment of timberlands. The company operates through Southern Timber, Pacific Northwest Timber, and Real Estate segments. The Southern Timber and Pacific Northwest Timber segments are involved in harvesting timber and related activities, as well as value-added services such as licensing properties for hunting, leasing land for mineral extraction and communication infrastructure, land-based solutions including carbon capture and solar energy, and log trading. The Real Estate segment is engaged in land sales across various categories, as well as residential and commercial leasing activities. It generates the majority of its revenue from the Southern Timber segment.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: